Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD

L. Feng Ming, W. ZengLi (Chengdu, China)

Source: Annual Congress 2002 - Acute exacerbations of COPD: aetiology and therapy
Session: Acute exacerbations of COPD: aetiology and therapy
Session type: Thematic Poster Session
Number: 3364
Disease area: Airway diseases

Congress or journal article abstract

Abstract

CCSP (Clara cell secretory protein) is an important constitutive protein, which modulates the lung inflammatory responses. Recruitment of neutrophils and macrophages in lung plays an important role in the pulmonary infection and also in the pathogenesis of COPD. Recent studies showed that CCSP inhibits the chemotaxis of macrophages and neutrophils and then suppress the lung inflammation. In this study, we determined the CCSP level (Western blot) and its mRNA expression (RT-PCR), neutrophils elastase (NE)(Meosuc-ala-ala-val-pro-NA method), MIP(marophage infammation protein)-1αand MIP-2 (ELISA) in induced sputum of COPD patients with acute bacterial exacerbation (12 cases) and normal controls (10 cases). The concentration of CCSP and its mRNA expression decreased in COPD patients during acute bacterial exacerbation (p<0.001) and increased after the resolution of infection (p<0.001), but still lower than normal controls (p<0.05). MIP-1α, MIP-2 and NE increased during lung infection but decreased after lung infection (p<0.001). The CCSP and its mRNA expression both significantly negative correlated with the number of neutrophils and macrophages, MIP-1α, MIP-2 and NE. The present results suggested that decreased CCSP may increase neutrophils and macrophages recruitment in the lung, which help the resolution of infection. More neutrophils and macrophages also induced lung tissue destroying which lead to further aggravate of COPD course.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Feng Ming, W. ZengLi (Chengdu, China). Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD. Eur Respir J 2002; 20: Suppl. 38, 3364

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Similar sputum secretory leykocyte inhibitor and Clara cell protein 16 levels between current and ex-smokers with COPD
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008

Reduced bronchial epithelial Smad7 protein expression in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 3s
Year: 2005

Cytokine receptors expression in induced sputum in asthma and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001

Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients
Source: Annual Congress 2009 - Pathology and immunology of COPD
Year: 2009

CysLT1 receptor gene and protein expression in bronchial biopsies of chronic bronchitis when stable and in exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006

MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

Expression of selected surface markers on macrophages in induced sputum from patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Effect of QVAR® on inflammatory cells and cytokine gene expression in early and late sputum samples in asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 502s
Year: 2002

Sputum macrophages in chronic bronchitis are activated, steroid resistant and drive epithelial MUC5B
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Increased apoptosis in induced sputum cells in stable COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 584s
Year: 2007

Bronchial mucosal dendritic cells and VEGF expression in COPD patients
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012


Assessment of cytokine mRNA expression in patients with COPD exacerbations
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

Anti-rhinoviral activity of soluble ICAM-1/FC fusion protein in primary airway epithelial cells from COPD patients
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009


Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression
Source: Eur Respir J, 49 (5) 1602006; 10.1183/13993003.02006-2016
Year: 2017



Changes in the induced sputum proteome during COPD exacerbations
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020


Role of Clara cell protein (CC)- 10 in the regulation of allergic airway inflammation and tolerance induction in mice
Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models
Year: 2008

Association between bacterial load and inflammatory gene expression in COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




The influence of gluco-corticoids (GC) on the apoptosis of activated cells in the induced sputum of patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002

Expression of MMP-8 protein in alveolar macrophages is related to bronchial asthma severity and treatment efficacy
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010

Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019